Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 ...

Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...

An experimental weight-loss drug from Eli Lilly led to more than twice the average weight loss of Ozempic in a clinical trial ...

Stanford researchers have discovered an AI-identified natural molecule that dramatically suppresses appetite and promotes fat ...

The ‘triple G’ experimental drug also led to greater reductions in A1C. Drugmaker Lilly is expected to apply for FDA approval ...

Eli Lilly's experimental weight-loss drug retatrutide outperformed Ozempic in a clinical trial, but FDA approval is still ...

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Amrita Arora Ladak has undergone a significant transformation, shedding 14 kg and embracing a journey of personal redemption. This endeavor has been both emotionally and physically taxing, yet ...